Eledon Pharmaceuticals (ELDN) EPS (Basic) Growth (3y) (2016 - 2026)
Eledon Pharmaceuticals (ELDN) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
41.58% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
85.94% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Eledon Pharmaceuticals |
401.35 Mn |
185.32 Mn |
- |
23.94% |
| Date | Value |
|---|
| Mar 31, 2026 |
23.94% |
| Dec 31, 2025 |
64.05% |
| Sep 30, 2025 |
33.99% |
| Jun 30, 2025 |
41.52% |
| Mar 31, 2025 |
51.24% |
| Dec 31, 2024 |
-9.60% |
| Sep 30, 2024 |
53.13% |
| Jun 30, 2024 |
-28.46% |
| Mar 31, 2024 |
-298.68% |
| Dec 31, 2023 |
-64.20% |
| Sep 30, 2023 |
60.88% |
| Jun 30, 2023 |
0.00% |
| Mar 31, 2023 |
55.52% |
| Dec 31, 2022 |
10.37% |
| Sep 30, 2022 |
43.32% |
| Jun 30, 2022 |
-22.92% |
| Mar 31, 2022 |
-9.89% |
| Dec 31, 2021 |
-6.98% |
| Sep 30, 2021 |
-21.28% |
| Jun 30, 2021 |
-13.72% |
